Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

422
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

275
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN DIFFERENT STAGES OF DISEASE: A REPORT FROM SOUTHERN IRAN

Pages

  0-0

Abstract

 Background: HEPATITIS C virus (HCV) infection is a major blood-borne infection which imposes high economic COST on the patients.Objectives: The current study aimed to evaluate the total annual COST due to chronic HCV related diseases imposed on each patient and their family in Southern Iran.Patients and Methods: Economic burden of chronic HEPATITIS C-related liver diseases (chronic HEPATITIS C, CIRRHOSIS and HEPATOCELLULAR CARCINOMA) were examined. The current retrospective study evaluated 200 Iranian patients for their socioeconomic status, utilization (direct and indirect COSTs) and treatment COSTs and work days lost due to illness by a structured questionnaire in 2015.Costs of hospital admissions were extracted from databases of Nemazee hospital, Shiraz, Iran. The outpatient expenditure per patient was measured through the rate of outpatient visits and average COST per visit reported by the patients; while the inpatient COSTs were calculated through annual rate of hospital admissions and average expenditure. Self-medication and direct non-medical COSTs were also reported. The human capital approach was used to measure the work loss COST.Results: The total annual COST per patient for chronic HEPATITIS C, CIRRHOSISandhepatocellular carcinoma (HCC) basedonpurchasing power parity (PPP) were USD 1625.50, USD 6117.2, and USD 11047.2 in 2015, respectively.Conclusions: Chronic HEPATITIS C-related liver diseases impose a substantial economic burden on patients, families and the society.The current study provides useful information on COST of treatment and work loss for different disease states, which can be further used in COST-effectiveness evaluations.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    ZARE, FATEMEH, FATTAHI, MOHAMMAD REZA, SEPEHRIMANESH, MASOOD, & SAFARPOUR, ALI REZA. (2016). ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN DIFFERENT STAGES OF DISEASE: A REPORT FROM SOUTHERN IRAN. HEPATITIS MONTHLY, 16(4), 0-0. SID. https://sid.ir/paper/306996/en

    Vancouver: Copy

    ZARE FATEMEH, FATTAHI MOHAMMAD REZA, SEPEHRIMANESH MASOOD, SAFARPOUR ALI REZA. ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN DIFFERENT STAGES OF DISEASE: A REPORT FROM SOUTHERN IRAN. HEPATITIS MONTHLY[Internet]. 2016;16(4):0-0. Available from: https://sid.ir/paper/306996/en

    IEEE: Copy

    FATEMEH ZARE, MOHAMMAD REZA FATTAHI, MASOOD SEPEHRIMANESH, and ALI REZA SAFARPOUR, “ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN DIFFERENT STAGES OF DISEASE: A REPORT FROM SOUTHERN IRAN,” HEPATITIS MONTHLY, vol. 16, no. 4, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/306996/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top